These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 11688428)

  • 1. [Efficacy of pilsicainide for the long-term prevention of paroxysmal atrial fibrillation: analysis based on the time of onset].
    Komatsu T; Nakamura S; Kimura M; Owada S; Tomita H; Yomogida K; Okumura K
    J Cardiol; 2001 Oct; 38(4):211-7. PubMed ID: 11688428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy of cibenzoline in the termination and long-term prevention of paroxysmal atrial fibrillation: analysis based on the time of onset].
    Komatsu T; Nakamura S; Kimura M; Owada S; Saito E; Kobayashi T; Okumura K
    J Cardiol; 2001 Feb; 37(2):75-82. PubMed ID: 11255698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relationship between duration of arrhythmia and subsequent preventive effect of disopyramide after cardioversion in patients with symptomatic paroxysmal and persistent atrial fibrillation].
    Komatsu T; Yomogida K; Nakamura S; Suzuki O; Horiuchi D; Kameda K; Tomita H; Abe N; Owada S; Oikawa K; Okumura K
    J Cardiol; 2003 Sep; 42(3):111-7. PubMed ID: 14526660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Long-term efficacy of combination therapy using antiarrhythmic agents and angiotensin converting enzyme inhibitor in patients with paroxysmal and persistent atrial fibrillation: importance of the timing of administration].
    Komatsu T; Nakamura S; Suzuki O; Horiuchi D; Owada S; Kameda K; Tomita H; Oikawa K; Abe N; Okumura K
    J Cardiol; 2003 Feb; 41(2):73-80. PubMed ID: 12649925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Relationship between long-term preventive efficacy of cibenzoline and atrial natriuretic peptide in patients with paroxysmal atrial fibrillation].
    Komatsu T; Nakamura S; Kimura M; Owada S; Yomogida K; Kameda K; Oikawa K; Tomita H; Okumura K
    J Cardiol; 2002 Feb; 39(2):93-9. PubMed ID: 11873440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Factors for successful conversion of atrial fibrillation using intravenous injection of pilsicainide hydrochloride].
    Matsushita K; Ishikawa T; Sumita S; Kobayashi T; Matsumoto K; Yamakawa Y; Ohkusu Y; Nakagawa T; Nakazawa I; Mochida Y; Ebina T; Uchino K; Kimura K; Umemura S
    J Cardiol; 2003 Aug; 42(2):81-6. PubMed ID: 12964518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term efficacy and safety of very-low-dose amiodarone treatment for the maintenance of sinus rhythm in patients with chronic atrial fibrillation after successful direct-current cardioversion.
    Jong GP; Chang MH; Chang TC; Chou P; Fu CY; Tien LY; Chen CY; Ma TC
    Chin Med J (Engl); 2006 Dec; 119(24):2030-5. PubMed ID: 17199952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long-term preventive effect and safety of amiodarone in patients with paroxysmal atrial fibrillation refractory to class I antiarrhythmic agents: analysis based on patient profiles].
    Komatsu T; Horiuchi D; Nakamura S; Suzuki O; Yomogida K; Okumura K
    J Cardiol; 2005 Jan; 45(1):11-7. PubMed ID: 15700925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ibutilide in persistent atrial fibrillation refractory to conventional cardioversion methods.
    Naegeli B; Straumann E; Bertel O
    Int J Cardiol; 2005 Mar; 99(2):283-7. PubMed ID: 15749188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pilsicainide for conversion and maintenance of sinus rhythm in chronic atrial fibrillation: a placebo-controlled, multicenter study.
    Okishige K; Nishizaki M; Azegami K; Igawa M; Yamawaki N; Aonuma K;
    Am Heart J; 2000 Sep; 140(3):e13. PubMed ID: 10966544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of pilsicainide hydrochloride on atrial fibrillation threshold].
    Ishibashi K; Inoue D; Omori I; Shirayama T; Inoue M; Sakai R; Yamahara Y; Asayama J; Nakagawa M
    Kokyu To Junkan; 1993 Aug; 41(8):763-7. PubMed ID: 8351435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized crossover study of the long-term effects of pilsicainide and cibenzoline in preventing recurrence of symptomatic paroxysmal atrial fibrillation: influence of the duration of arrhythmia before therapy.
    Komatsu T; Sato Y; Tachibana H; Nakamura M; Horiuchi D; Okumura K
    Circ J; 2006 Jun; 70(6):667-72. PubMed ID: 16723785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of atrial fibrillation in a Hungarian hospital department of cardiologic internal medicine at the turn of the millennium].
    Márk L; Erdej F; Dani G; Borbély M; Sziklai G; Nagy E; Hajdara I; Katona A
    Orv Hetil; 2004 May; 145(19):1001-6. PubMed ID: 15181735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation of C-reactive protein to long-term risk of recurrence of atrial fibrillation after electrical cardioversion.
    Loricchio ML; Cianfrocca C; Pasceri V; Bianconi L; Auriti A; Calo L; Lamberti F; Castro A; Pandozi C; Palamara A; Santini M
    Am J Cardiol; 2007 May; 99(10):1421-4. PubMed ID: 17493472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Facilitating internal cardioversion of chronic atrial fibrillation with ibutilide--predictors of atrial defibrillation-threshold decrease.
    Efremidis M; Sideris A; Batra R; Manolatos D; Xidonas S; Kardara D; Ekonomou D; Evagelou D; Filippatos G; Kardaras F
    Med Sci Monit; 2004 Jun; 10(6):CR258-63. PubMed ID: 15173670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P wave dispersion and short-term vs. late atrial fibrillation recurrences after cardioversion.
    Boriani G; Diemberger I; Biffi M; Camanini C; Valzania C; Corazza I; Martignani C; Zannoli R; Branzi A
    Int J Cardiol; 2005 Jun; 101(3):355-61. PubMed ID: 15907401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ibutilide added to propafenone for the conversion of atrial fibrillation and atrial flutter.
    Chiladakis JA; Kalogeropoulos A; Patsouras N; Manolis AS
    J Am Coll Cardiol; 2004 Aug; 44(4):859-63. PubMed ID: 15312872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inefficiency of renin-angiotensin inhibitors in preventing atrial fibrillation in patients with a normal heart.
    Fazio G; Pizzuto C; Sutera L; Guttilla D; Di Gesaro G; Cascio C; Novo G; Assennato P; Novo S
    Minerva Cardioangiol; 2007 Jun; 55(3):311-5. PubMed ID: 17534249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term rhythm control of drug-refractory atrial fibrillation with "hybrid therapy" incorporating dual-site right atrial pacing, antiarrhythmic drugs, and right atrial ablation.
    Madan N; Saksena S
    Am J Cardiol; 2004 Mar; 93(5):569-75. PubMed ID: 14996581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atrial fibrillation: rate control often better than rhythm control.
    Prescrire Int; 2004 Apr; 13(70):64-9. PubMed ID: 15148984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.